By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported an 8 percent decrease in year-over-year revenues for its third quarter due to divestitures in 2009-2010, but on an organic basis revenues were up 11 percent.

The Hopkinton, Mass.-based firm had total revenues of $29.7 million for the three-month period ended Sept. 30, compared to $32.2 million for the third quarter of 2009. It beat analysts' consensus estimate for revenues of $27.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.